Loss of 14q31-q32.2 in renal cell carcinoma is associated with high malignancy grade and poor survival.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  International Journal of Oncology

• Publication date

  2004-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/IJO.25.1.179PMID 15202004
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chromosome 14q LOH in localized clear cell renal cell carcinoma

  2002cited by this paper
• Contemporary approach to the classification of renal epithelial tumors.

  2000cited by this paper
• Prognostic Significance of the Heidelberg Classification of Renal Cell Carcinoma

  1999cited by this paper
• Lack of genetic changes at specific genomic sites separates renal oncocytomas from renal cell carcinomas

  1998cited by this paper
• The Heidelberg classification of renal cell tumours

  1997cited by this paper
• Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas

  1997cited by this paper
• Significance of chromosome arm 14q loss in nonpapillary renal cell carcinomas

  1997cited by this paper
• The correlation between the loss of chromosome 14q with histologic tumor grade, pathologic stage, and outcome of patients with nonpapillary renal cell carcinoma.

  1996cited by this paper
• Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in 148 renal cell carcinomas

  1996cited by this paper
• A comprehensive genetic map of the human genome based on 5,264 microsatellites

  1996cited by this paper
• Adult renal epithelial neoplasms.

  1995cited by this paper
• Chromophobe cell renal carcinoma: clinicopathological features of 50 cases.

  1995cited by this paper
• Deletion mapping in human renal cell carcinoma.

  1989cited by this paper
• Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas.

  1989cited by this paper
• Prognostic significance of morphologic parameters in renal cell carcinoma

  1982cited by this paper

• Pathological and genetic markers improve recurrence prognostication with the University of California Los Angeles Integrated Staging System for patients with clear cell renal cell carcinoma.

  2022cites this paper
• SERPINA5 promotes tumour cell proliferation by modulating the PI3K/AKT/mTOR signalling pathway in gastric cancer

  2022cites this paper
• Hypoxia, angiogenesis, and metabolism in the hereditary kidney cancers

  2019cites this paper
• Molecular Biology and Genetics of Renal Cell Carcinoma

  2019cites this paper
• Downregulation of long noncoding RNA LINC00683 associated with unfavorable prognosis in prostate cancer based on TCGA

  2019cites this paper
• Importance of miR-299-5p in colorectal cancer

  2017cites this paper
• The Value of miR-299-5p in Diagnosis and Prognosis of Intestinal-Type Gastric Adenocarcinoma

  2016cites this paper
• Downregulation of WDR20 due to loss of 14q is involved in the malignant transformation of clear cell renal cell carcinoma

  2016cites this paper
• Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms

  2015cites this paper
• DNA promoter hypermethylation contributes to down-regulation of galactocerebrosidase gene in lung and head and neck cancers.

  2015cites this paper
• Predictive chromosomal clusters of synchronous and metachronous brain metastases in clear cell renal cell carcinoma.

  2014cites this paper
• SERPINA5 inhibits tumor cell migration by modulating the fibronectin‐integrin β1 signaling pathway in hepatocellular carcinoma

  2014cites this paper
• Molecular targets on the horizon for kidney and urothelial cancer

  2013cites this paper
• Polymorphism in protein tyrosine phosphatase receptor delta is associated with the risk of clear cell renal cell carcinoma.

  2013cites this paper
• Molecular Characterization of Renal Cell Carcinoma

  2012cites this paper
• Renal Cell Carcinoma Deep Sequencing: Recent Developments

  2012cites this paper
• Tissue Biomarkers in Renal Cell Carcinoma: Intermediate Endpoints in the Selection of Targeted Agents for RCC

  2012cites this paper
• D9S168 microsatellite alteration predicts a poor prognosis in patients with clear cell renal cell carcinoma and correlates with the down‐regulation of protein tyrosine phosphatase receptor delta

  2011cites this paper
• Genetic and functional studies implicate HIF1α as a 14q kidney cancer suppressor gene.

  2011cites this paper
• Copy number profiling in von hippel‐lindau disease renal cell carcinoma

  2011cites this paper
• Chromosome 14q loss defines a molecular subtype of clear-cell renal cell carcinoma associated with poor prognosis

  2011cites this paper
• Renal Cell Carcinoma

  2011cites this paper
• Clinical significance of genome‐wide minimally deleted regions in oral squamous cell carcinomas

  2011cites this paper
• Prognostic value of cytogenetic analysis in clear cell renal carcinoma: a study on 131 patients with long-term follow-up.

  2010cites this paper
• Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.

  2009cites this paper
• Virtual-Karyotyping With SNP Microarrays in Morphologically Challenging Renal Cell Neoplasms: A Practical and Useful Diagnostic Modality

  2009cites this paper
• Genome‐wide profiling of chromosomal alterations in renal cell carcinoma using high‐density single nucleotide polymorphism arrays

  2009cites this paper
• Identification of copy number alterations and its association with pathological features in clear cell and papillary RCC.

  2008cites this paper
• Chromosomal Aberrations in a Case of Synchronous Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Type and Bronchogenic Adenocarcinoma

  2008cites this paper
• Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping array.

  2008cites this paper
• Analysis of Allelic Loss as an Adjuvant Tool in Evaluation of Malignancy in Uterine Smooth Muscle Tumors

  2006cites this paper
• Identification of a 7.1-mega base pairs minimal deletion at 14q31.1-32.11 in adenocarcinomas of the gastroesophageal junction.

  2006cites this paper
• Nucleic acid-based marker approaches to urologic cancers.

  2006cites this paper
• Head and Neck

  2005cites this paper
• CHES1/FOXN3 interacts with Ski-interacting protein and acts as a transcriptional repressor.

  2005cites this paper